FDA Mammo Definition Key To New Breast Cancer Screening Benefits – CMS
This article was originally published in The Gray Sheet
Executive Summary
Eventual coverage of breast cancer screening technologies beyond mammography is contingent on revisions to FDA regulatory language, CMS Chief Medical Officer Sean Tunis warned June 14